Engineering Medicines To Improve Patient Care Deepa Rajagopalan, M.D. SVP, New Product and Portfolio Development Deepa Rajagopalan joined Viridian in 2021 to lead New Products and Portfolio Development. She joins us from Intercept where she was most recently VP of New Products. In this role, Deepa led commercial planning, early-stage development, and corporate development for Intercept’s pipeline. Prior to that she held strategy and global marketing roles at Alexion. Previously, Deepa was a leader in the healthcare consulting practice at Bain & Company and built and led the biopharma commercial strategy practice at Science Group PLC. She previously trained as a surgical resident at the Cleveland Clinic Health System and at Western Pennsylvania Hospital. Deepa received an M.D. from University of Delhi and an M.B.A. from London Business School.